+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
APLLTD

Alembic Pharmaceuticals Share Price

 
32.08% Gain from 52W Low

 

Alembic Pharmaceuticals live price: ₹839.75. It opened at ₹851 vs previous close ₹850; intraday high/low: ₹855/₹837. The 50 & 200 DMA stand at ₹783.30/₹806.90.

Alembic Pharmaceuticals Performance

  • Today's Low
  • ₹837
  • Today's High
  • ₹855
  • 52 Week Low
  • ₹636
  • 52 Week High
  • ₹1,044
  • Open Price₹851
  • Previous Close₹850
  • Volume101,759
  • 50 DMA₹783.30
  • 100 DMA₹778.10
  • 200 DMA₹806.90

Alembic Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 13.83%
  • Over 3 Month + 14.28%
  • Over 6 Month + 6.31%
  • Over 1 Year -18.51%

Smart Investing Starts Here Start SIP with Alembic Pharmaceuticals for Steady Growth!

Invest Now

Alembic Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.5
  • PEG Ratio
  • 1.6
  • Market Cap Cr
  • 16,506
  • P/B Ratio
  • 2.9
  • Average True Range
  • 24.6
  • EPS
  • 34.3
  • Dividend Yield
  • 1.3
  • MACD Signal
  • 21.2
  • RSI
  • 62.45
  • MFI
  • 82.68

Latest Stock News Updates

Alembic Pharmaceuticals Ltd - 533573 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Please find enclosed.

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed herewith the copy of the Newspaper Publication published on 11th July, 2026.

Alembic Pharmaceuticals Ltd - 533573 - Specimen Copy Of The Letter Sent To The Shareholders Under Regulation 36(1)(B) Of SEBI LODR

Please find enclosed.

Alembic Pharmaceuticals Financials

Alembic Pharmaceuticals Technicals

EMA & SMA

Current Price
₹839.75
-10.3 (-1.21%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹810.70
  • 50 Day
  • ₹783.30
  • 100 Day
  • ₹778.10
  • 200 Day
  • ₹806.90

Resistance and Support

844.08 Pivot Speed
  • R3 869.40
  • R2 862.40
  • R1 851.10
  • S1 832.80
  • S2 825.80
  • S3 814.50

Alembic Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-15 Audited Results & Final Dividend
2026-02-05 Quarterly Results
2025-11-04 Quarterly Results & Others To consider other business matters.
2025-08-05 Quarterly Results & Others To consider other business matters.
2025-05-06 Audited Results & Final Dividend
Date Purpose Remarks
2026-07-29 FINAL Rs.12.00 per share(600%)Final Dividend
2025-07-29 FINAL Rs.11.00 per share(550%)Final Dividend
2024-07-15 FINAL Rs.11.00 per share(550%)Final Dividend
2023-07-28 FINAL Rs.8.00 per share(400%)Final Dividend
2022-08-18 INTERIM Rs.10.00 per share(500%)Dividend (Changed Final Dividend as Interim Divided)
View Alembic Pharmaceuticals Dividend History Arrow

Alembic Pharmaceuticals Shareholding Pattern

69.87%
10%
8.73%
7.2%
4.17%

About Alembic Pharmaceuticals

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. View More
  • NSE Symbol
  • APLLTD
  • BSE Symbol
  • 533573
  • ISIN
  • INE901L01018

Similar Stocks to Alembic Pharmaceuticals

Alembic Pharmaceuticals FAQs

Alembic Pharmaceuticals share price is ₹839 As on 16 July, 2026 | 21:43

The Market Cap of Alembic Pharmaceuticals is ₹16506.4 Cr As on 16 July, 2026 | 21:43

The P/E ratio of Alembic Pharmaceuticals is 24.5 As on 16 July, 2026 | 21:43

The PB ratio of Alembic Pharmaceuticals is 2.9 As on 16 July, 2026 | 21:43

The 52 week High & Low of Alembic Pharmaceuticals is ₹1044/₹635.8 respectively As on 16 July, 2026 | 21:43

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23